-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Elicio Therapeutics, Inc. quarterly/annual Revenues history and growth rate from Q1 2020 to Q1 2023.
- Elicio Therapeutics, Inc. Revenues for the quarter ending March 31, 2023 was $0.000, a 100% decline year-over-year.
- Elicio Therapeutics, Inc. Revenues for the twelve months ending March 31, 2023 was $653K, a 97.8% decline year-over-year.
- Elicio Therapeutics, Inc. annual Revenues for 2022 was $2.3M, a 91.9% decline from 2021.
- Elicio Therapeutics, Inc. annual Revenues for 2021 was $28.3M, a 883% increase from 2020.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)